UA88711C2 - 4-hydroxy-2-oxo-1-propyl-1,2-dihydroquinoline-3-carboxylic acid diethylaminoethylamide methanesulfonate exhibiting local anaesthetic activity - Google Patents

4-hydroxy-2-oxo-1-propyl-1,2-dihydroquinoline-3-carboxylic acid diethylaminoethylamide methanesulfonate exhibiting local anaesthetic activity

Info

Publication number
UA88711C2
UA88711C2 UAA200801649A UAA200801649A UA88711C2 UA 88711 C2 UA88711 C2 UA 88711C2 UA A200801649 A UAA200801649 A UA A200801649A UA A200801649 A UAA200801649 A UA A200801649A UA 88711 C2 UA88711 C2 UA 88711C2
Authority
UA
Ukraine
Prior art keywords
carboxylic acid
dihydroquinoline
methanesulfonate
oxo
propyl
Prior art date
Application number
UAA200801649A
Other languages
Russian (ru)
Ukrainian (uk)
Inventor
Игорь Васильевич Украинец
Андрей Александрович Ткач
Виктория Владимировна Кравцова
Original Assignee
Українець Ігор Васильович
Ткач Андрій Олександрович
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Українець Ігор Васильович, Ткач Андрій Олександрович filed Critical Українець Ігор Васильович
Priority to UAA200801649A priority Critical patent/UA88711C2/en
Publication of UA88711C2 publication Critical patent/UA88711C2/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

The invention relates to chemico-pharmaceutical industry and concerns bioactive substances, in particular derivatives of quinoline-3-carboxylic acid, namely 4-hydroxy-2-oxo-1-propyl-1,2-dihydroquinoline-3-carboxylic acid diethylaminoethylamide methanesulfonate of formula: EMBED ISISServer , exhibiting local anaesthetic activity and at the same time improved pharmaceutical properties such as high water solubility and low level of irritant action.
UAA200801649A 2008-02-08 2008-02-08 4-hydroxy-2-oxo-1-propyl-1,2-dihydroquinoline-3-carboxylic acid diethylaminoethylamide methanesulfonate exhibiting local anaesthetic activity UA88711C2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
UAA200801649A UA88711C2 (en) 2008-02-08 2008-02-08 4-hydroxy-2-oxo-1-propyl-1,2-dihydroquinoline-3-carboxylic acid diethylaminoethylamide methanesulfonate exhibiting local anaesthetic activity

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
UAA200801649A UA88711C2 (en) 2008-02-08 2008-02-08 4-hydroxy-2-oxo-1-propyl-1,2-dihydroquinoline-3-carboxylic acid diethylaminoethylamide methanesulfonate exhibiting local anaesthetic activity

Publications (1)

Publication Number Publication Date
UA88711C2 true UA88711C2 (en) 2009-11-10

Family

ID=50637538

Family Applications (1)

Application Number Title Priority Date Filing Date
UAA200801649A UA88711C2 (en) 2008-02-08 2008-02-08 4-hydroxy-2-oxo-1-propyl-1,2-dihydroquinoline-3-carboxylic acid diethylaminoethylamide methanesulfonate exhibiting local anaesthetic activity

Country Status (1)

Country Link
UA (1) UA88711C2 (en)

Similar Documents

Publication Publication Date Title
PH12018500843A1 (en) Compositions and methods for treating and/or preventing cardiovascular disease
UA115983C2 (en) Dna-pk inhibitors
MA33803B1 (en) BENZODIAZEPINE BROMODOMAINE INHIBITOR
IN2012DN03312A (en)
EA201190217A1 (en) SUBSTITUTED 2-ACETAMIDO-5-ARIL-1,2,4-TRIAZOLONES AND THEIR APPLICATION
WO2014007951A3 (en) Substituted tricyclic compounds as fgfr inhibitors
IN2012DN03883A (en)
EA201200323A1 (en) COMPOUNDS AND COMPOSITIONS AS PROTEINKINASE INHIBITORS
UA111464C2 (en) The composition containing c1-c7 and glycerin, and its use as antibacterial and inhibiting agent
MX350088B (en) Stable pharmaceutical composition and methods of using same.
MX2011014019A (en) Diazahomoadamantane derivatives and methods of use thereof.
MY161597A (en) Antimicrobial compositions
MX342947B (en) Treatment of type 2 diabetes.
MX340983B (en) Pharmaceutical and nutraceutical compositions of abscisic acid.
TW201129396A (en) Topical formulation
UA103996C2 (en) Ivabradine hydrobromide
MX2010002812A (en) Food compositions comprising lemon balm extracts.
PT1981862E (en) Lanthionine-related compounds for the treatment of inflammatory diseases
MX2010009999A (en) 3-trifluoromethyl-pyrazine-2-carboxylic acid amide derivatives as hdl-cholesterol raising agents.
MX2012002165A (en) Silicone modified fatty acids, method of preparation and usage thereof.
WO2010042212A3 (en) Methods for treating or preventing pain using spicamycin derivatives
MX2015001648A (en) Compositions comprising spicamycin derivatives and methods of use thereof.
SMT201300112B (en) Citrate salt of 9E-15- (2-pyrrolidin-1-yl-ethoxy) -7,12,25-triossa-19,21,24-triaza-tetracycloÄ18.3.1.1 (2,5) .1 (14, 18) Üesacos a-1 (24), 2,4,9,14,16,18 (26), 20,22-nonaene
WO2010075086A3 (en) Pyrrolidinone inhibitors of pde-4
UA88711C2 (en) 4-hydroxy-2-oxo-1-propyl-1,2-dihydroquinoline-3-carboxylic acid diethylaminoethylamide methanesulfonate exhibiting local anaesthetic activity